Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Clinical factors that predict noncirrhotic portal hypertension in HIV-infected patients: a proposed diagnostic algorithm.

Parikh ND, Martel-Laferriere V, Kushner T, Childs K, Vachon ML, Dronamraju D, Taylor C, Fiel MI, Schiano T, Nelson M, Agarwal K, Dieterich DT.

J Infect Dis. 2014 Mar 1;209(5):734-8. doi: 10.1093/infdis/jit412. Epub 2013 Aug 2.

PMID:
23911709
2.

Noncirrhotic portal hypertension: another cause of liver disease in HIV patients.

Mendizabal M, Craviotto S, Chen T, Silva MO, Reddy KR.

Ann Hepatol. 2009 Oct-Dec;8(4):390-5.

PMID:
20009143
3.

Genetic determinants of idiopathic noncirrhotic portal hypertension in HIV-infected patients.

Vispo E, Cevik M, Rockstroh JK, Barreiro P, Nelson M, Scourfield A, Boesecke C, Wasmuth JC, Soriano V; European Network of Clinical Trials (NEAT)..

Clin Infect Dis. 2013 Apr;56(8):1117-22. doi: 10.1093/cid/cit001. Epub 2013 Jan 11.

PMID:
23315321
4.

Noncirrhotic portal hypertension in patients with human immunodeficiency virus-1 infection.

Saifee S, Joelson D, Braude J, Shrestha R, Johnson M, Sellers M, Galambos MR, Rubin RA.

Clin Gastroenterol Hepatol. 2008 Oct;6(10):1167-9. doi: 10.1016/j.cgh.2008.04.023. Epub 2008 Jul 17.

PMID:
18639498
5.

Splenomegaly and variceal bleeding in a ten-year-old HIV-infected girl with noncirrhotic portal hypertension.

Giacomet V, Viganò A, Penagini F, Manfredini V, Maconi G, Camozzi M, Zuccotti GV.

Pediatr Infect Dis J. 2012 Oct;31(10):1059-60. doi: 10.1097/INF.0b013e3182694126.

PMID:
22828640
6.

Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study.

Kovari H, Ledergerber B, Peter U, Flepp M, Jost J, Schmid P, Calmy A, Mueller NJ, Muellhaupt B, Weber R; Swiss HIV Cohort Study..

Clin Infect Dis. 2009 Aug 15;49(4):626-35. doi: 10.1086/603559.

PMID:
19589079
7.

Noncirrhotic portal hypertension in HIV-infected patients: a case control evaluation and review of the literature.

Cesari M, Schiavini M, Marchetti G, Caramma I, Ortu M, Franzetti F, Galli M, Antinori S, Milazzo L.

AIDS Patient Care STDS. 2010 Nov;24(11):697-703. doi: 10.1089/apc.2010.0160. Epub 2010 Oct 23. Review.

PMID:
20969464
8.

A case of non-cirrhotic portal hypertension associated with anti-retroviral therapy in a Japanese patient with human immunodeficiency virus infection.

Yajima K, Uehira T, Otera H, Koizumi Y, Watanabe D, Kodama Y, Kuzushita N, Nishida Y, Mita E, Mano M, Shirasaka T.

J Infect Chemother. 2014 Sep;20(9):582-5. doi: 10.1016/j.jiac.2014.06.005. Epub 2014 Jul 15.

PMID:
25034388
9.

Noncirrhotic portal hypertension in HIV infection.

Vispo E, Morello J, Rodriguez-Novoa S, Soriano V.

Curr Opin Infect Dis. 2011 Feb;24(1):12-8. doi: 10.1097/QCO.0b013e3283420f08. Review.

PMID:
21157331
10.

[Noncirrhotic portal hypertension in a human immunodeficiency virus (HIV) infected adolescent].

Gouvêa Ade F, Machado DM, Beltrão SC, Carmo FB, Mattar RH, Succi RC.

Rev Paul Pediatr. 2015 Apr-Jun;33(2):246-50. doi: 10.1016/j.rpped.2014.09.001. Epub 2015 Mar 27. Portuguese.

11.

Risk factors and outcome of HIV-associated idiopathic noncirrhotic portal hypertension.

Schouten JN, Van der Ende ME, Koëter T, Rossing HH, Komuta M, Verheij J, van der Valk M, Hansen BE, Janssen HL.

Aliment Pharmacol Ther. 2012 Nov;36(9):875-85.

12.

Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV.

Schiano TD, Kotler DP, Ferran E, Fiel MI.

Am J Gastroenterol. 2007 Nov;102(11):2536-40. Epub 2007 Jul 19.

PMID:
17640321
13.

Noncirrhotic portal hypertension associated with didanosine: a case report and literature review.

Chang HM, Tsai HC, Lee SS, Wann SR, Chen YS.

Jpn J Infect Dis. 2012;65(1):61-5. Review.

14.

Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings.

Vispo E, Moreno A, Maida I, Barreiro P, Cuevas A, Albertos S, Soriano V.

AIDS. 2010 May 15;24(8):1171-6. doi: 10.1097/QAD.0b013e3283389e26.

PMID:
20299955
15.

Non-cirrhotic portal hypertension in HIV-infected individuals.

Scourfield A, Waters L, Holmes P, Panos G, Randell P, Jackson A, Mandalia S, Gazzard B, Nelson M.

Int J STD AIDS. 2011 Jun;22(6):324-8. doi: 10.1258/ijsa.2010.010396.

PMID:
21680667
16.

Noncirrhotic portal hypertension in the adult: case report and review of the literature.

Almoudarres M, Vega KJ, Trotman BW.

J Assoc Acad Minor Phys. 1998;9(3):53-5. Review.

PMID:
9747059
17.

Surgical and endovascular treatment of severe complications secondary to noncirrhotic portal hypertension: experience of 56 cases.

Wu J, Li Z, Wang Z, Han X, Ji F, Zhang WW.

Ann Vasc Surg. 2013 May;27(4):441-6. doi: 10.1016/j.avsg.2012.05.027. Epub 2013 Mar 7.

PMID:
23465435
18.

The development of hepatoportal sclerosis and portal hypertension due to didanosine use in HIV.

Schiano TD, Uriel A, Dieterich DT, Fiel MI.

Virchows Arch. 2011 Feb;458(2):231-5. doi: 10.1007/s00428-010-1004-7. Epub 2010 Nov 6.

PMID:
21057809
19.

[Non-cirrhotic portal hypertension: rare cause of upper gastrointestinal bleeding].

Schouten JN, Verheij J, Janssen HL.

Ned Tijdschr Geneeskd. 2010;154:A1276. Dutch.

PMID:
20456763
20.

Didanosine Exposure and Noncirrhotic Portal Hypertension in a HIV Clinic in North America: a Follow-up Study.

Cachay ER, Peterson MR, Goicoechea M, Mathews WC.

Br J Med Med Res. 2011;1(4):346-355.

Supplemental Content

Support Center